ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

March 21, 1997

Study Section Members Seek NIH Use Of Normalization, Sliding Scale

April 16, 1982

New Research Projects Proposed For Immunology

September 30, 1977

Steiner To Leave ICC, Says Someone Else May Do Better

December 10, 1982

Colorectal Cancer Incidence Rising Worldwide

June 12, 2009